National Institute for Health and Care Research

Name

National Institute for Health and Care Research

Legal name

National Institute for Health and Care Research

Website

https://arc-nenc.nihr.ac.uk

Company type

Public

Founded year

2006

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

The UK's largest government-funded health and care research institute, providing grant funding and infrastructure support to universities, NHS trusts, and clinical trial networks across the United Kingdom.

Ownership category

akta.pro rank

Product category

Public Health Research Funding

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB)

akta.pro secondary industries

Public Health Financing, Budgeting & Grants Management (HLAJAMAC), International & Global Public Health Aid Administration (Government Donors) (HLAJALAO), Global Health Financing Mechanisms & Pooled Funds (HLAJAOAC)

Keywords

• Health research funding
• Clinical trial commissioning
• Public health research
• Academic research grants
• NHS research partnerships

Headquarters

HQ city

Whitehall

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Government Funding: NIHR is funded by the UK Department of Health and Social Care to commission and fund health and care research, supporting clinical trials and academic research partnerships.

Distribution channels1 record

Marketing channels3 records

Core offering

NIHR is the UK government's primary funder of health and social care research, commissioning and funding clinical trials, academic studies, and public health initiatives across universities, NHS trusts, and research institutions. Its portfolio includes the UK Public Health Rapid Support Team, the MRC Centre of Research Excellence in Clinical Trial Innovation, and individual clinical trials such as the Scratch Less Study and the leramistat Phase II sarcopenia trial. Funding is allocated through government grants rather than commercial sales.

Product overview

The National Institute for Health and Care Research (NIHR) is a UK government-funded body that commissions and funds health and social care research rather than operating as a commercial product company. The organization funds clinical trials, research studies, and collaborative academic initiatives across multiple disease areas and public health topics. Funded research programs include the Scratch Less Study (an online clinical trial for eczema), the UK Public Health Rapid Support Team consortium (£18 million, five-year initiative for outbreak response), and the MRC Centre of Research Excellence in Clinical Trial Innovation (up to £50 million partnership for pioneering clinical trial approaches). NIHR also commissions research on adult social care workforce challenges and food safety/dark kitchen regulation. These are research funding programs and clinical investigations rather than commercial products or services.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Reduced clinical trial set-up time from 169 to 122 days toward 150-day target
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core and flagship.

• University of NottinghamcoreStrategic or Co-development Partner · 25 June 2026University of Nottingham leads the Scratch Less Study, an online clinical trial testing a three-part eczema intervention program in approximately 600 participants aged 8 and older over four months. NIHR provides funding for this clinical research initiative.
• Nottingham University Hospitals NHS TrustcoreStrategic or Co-development Partner · 25 June 2026NHS Trust partners with University of Nottingham to conduct the Scratch Less Study clinical trial funded by NIHR. The study tests whether an online program can effectively break the itch-scratch cycle that worsens eczema symptoms.
• London School of Hygiene & Tropical MedicinecoreStrategic or Co-development Partner · 16 June 2026LSHTM leads the research arm of the UK Public Health Rapid Support Team in an £18 million, five-year initiative to strengthen global outbreak response capabilities. Research covers equity, gender, mental health, One Health, diagnostics, and AI for epidemic preparedness.
• UK Public Health Rapid Support TeamflagshipStrategic or Co-development Partner · 16 June 2026UK-PHRST partnership with NIHR builds on a decade-long work since 2016 establishment following the West African Ebola crisis. Low-and-middle income country institutions co-lead research projects alongside UK institutions.
• IstessocoreStrategic or Co-development Partner · 16 June 2026Istesso conducts Phase II clinical trial of leramistat for sarcopenia in partnership with NIHR. The randomized, double-blind, placebo-controlled study (IST-03) evaluates drug effects on muscle quality, repair, and function at UK trial sites.
• Newcastle UniversitycoreStrategic or Co-development Partner · 16 June 2026Newcastle University serves as a trial site for Istesso's Phase II clinical trial of leramistat for sarcopenia, working in conjunction with NIHR to assess the drug's effects on muscle quality, repair, and function.
• Newcastle HospitalscoreStrategic or Co-development Partner · 16 June 2026Newcastle Hospitals serves as a clinical trial site for Istesso's Phase II study of leramistat, operating in conjunction with NIHR to evaluate muscle quality, repair, and function outcomes in sarcopenia patients.
• Multiple UK UniversitiescoreStrategic or Co-development Partner · 31 January 2026NIHR commissioned a university study establishing the first industry-wide definition of dark kitchens and using data-scraping methods to identify delivery-only operations. The study highlights regulatory gaps and concerns about public health, food safety transparency, and allergen risks.
• Medical Research Council (MRC) Centre of Research Excellence in Clinical Trial InnovationflagshipStrategic or Co-development Partner · 9 January 2026MRC Centre receives up to £50m from UK government in partnership with NIHR to develop pioneering approaches to clinical trial design and delivery. The centre aims to enable simultaneous testing of multiple drugs across multiple diseases and identify minimum effective doses, with goal of reducing 20-year timeline for bringing new treatments to clinical practice.
• Manchester Metropolitan UniversitycoreStrategic or Co-development Partner · 28 March 2025NIHR and Manchester Metropolitan University conducted a study on pay variation in adult social care, revealing a 35.6% pay gap (£7,617 annually) between care workers and NHS equivalents, with 29% of providers operating at a financial deficit.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Medical Research Council (MRC): MRC is the UK's primary government biomedical research funder and a core partner with NIHR (e.g., the £50m Clinical Trial Innovation Centre). Both share the mandate to fund health research through grants to UK universities and NHS settings, with overlapping council structures under UKRI.
• National Institutes of Health (NIH): NIH is the US federal government's primary agency for biomedical and public health research, directly analogous to NIHR in mandate, scale, and grant-based funding model. Both disburse billions in government funding to academic medical centers and serve as the largest national health research funders in their respective countries.
• Wellcome Trust: Wellcome is a major charitable funder of health research in the UK and globally, with a comparable mandate to support biomedical discovery, translational research, and clinical trials. While privately endowed rather than government-funded, Wellcome operates in the same funding category as NIHR and often co-funds initiatives.
• UK Research and Innovation (UKRI): UKRI is the umbrella non-departmental public body that funds research and innovation across the UK, and it is the parent organization of MRC and several other research councils that operate alongside NIHR. NIHR works closely with UKRI through co-funding mechanisms (e.g., the £50m MRC Centre partnership), making UKRI a structural peer in the UK research funding ecosystem.
• Cancer Research UK: Cancer Research UK is the world's largest independent cancer research funder, supporting clinical trials and translational research in UK academic and NHS settings. While disease-specific rather than generalist, it operates the same grant-based funding model as NIHR and frequently co-funds trials at NIHR-supported sites.
• National Health and Medical Research Council (NHMRC): NHMRC is the Australian government's primary health and medical research funding agency, distributing government grants to universities and medical research institutes. It is the closest international governmental analog to NIHR in mandate and structure.
• European Research Council (ERC): ERC is the EU's premier funding body for frontier research, including health and biomedical science. Although its scope is broader than NIHR's and based in Europe rather than the UK, it is a comparable public-sector research funder supporting investigator-led science.
• Bill & Melinda Gates Foundation: The Gates Foundation is one of the largest global health research funders, with significant programs in disease prevention, vaccine development, and outbreak preparedness. It is comparable to NIHR's global health arm (UK-PHRST) and co-funds research in LMICs that NIHR also supports.

Emerging players

• Medical Research Foundation: The Medical Research Foundation is a UK charity that funds early-career and translational medical researchers, operating at smaller scale but with a similar grant-based model to NIHR. It represents a smaller, emerging UK funder in the same category.

Regional players

• INSERM: INSERM is the French National Institute of Health and Medical Research, the largest public biomedical research organization in Europe. While INSERM primarily conducts intramural research rather than distributing grants, it is the closest European peer to NIHR in mandate and public-sector health research orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/NIHRresearch

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments48 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institute for Health and Care Research